SPHRY
STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. (SPHRY)
$59
About STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. (SPHRY)
Starpharma Holdings Ltd. engages in the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its pipeline and products include SN38, cabazitaxel, docetaxel, radiopharmaceuticals, antibody-drug conjugates, and anti-infective products. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Details
Daily high
$0.59
Daily low
$0.59
Price at open
$0.59
52 Week High
$0.90
52 Week Low
$0.52
Market cap
25.9M
Dividend yield
0.00%
Volume
286
Avg. volume
852
P/E ratio
-3.11
STARPHARMA HLDGS S/ADR by Starpharma Holdings Ltd. News
Details
Daily high
$0.59
Daily low
$0.59
Price at open
$0.59
52 Week High
$0.90
52 Week Low
$0.52
Market cap
25.9M
Dividend yield
0.00%
Volume
286
Avg. volume
852
P/E ratio
-3.11